TCL Archive Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director January 6, 1989
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Hellman Will Leave Harvard To Become Physician In Chief At Memorial. James Awards Announced April 22, 1983
